28.1 C
Vientiane
Thursday, September 18, 2025
spot_img
Home Blog Page 4

Stanford Advanced Materials Announces New Series of Optical and Nonlinear Crystals to Facilitate Photonics and Laser R&D

SANTA ANA, Calif., Sept. 17, 2025 /PRNewswire/ — Stanford Advanced Materials (SAM) is pleased to announce the launch of a new series of optical and nonlinear crystals. The new series will target meeting the growing and diverse demands of photonics, laser research, and high-precision optical applications. SAM continues to demonstrate its commitment to innovation, quality, and tailored solutions for global customers.

SAM's Nonlinear Crystals
SAM’s Nonlinear Crystals

SAM introduces five exclusive additions to the catalogue range: PPLN, MGLN, BIBO, CaF₂, and PPKTP.

PPLN (Periodically Poled Lithium Niobate)

PPLN delivers high-efficiency nonlinear wavelength conversion, with a broad transparency range from 350–5200 nm and versatile quasi-phase-matching structures. Its high nonlinear coefficient and stable performance under controlled temperatures make it ideal for compact, cost-effective laser systems and precision photonics setups. Typical applications include SHG, OPO, DFG, SFG, and quantum optics experiments.

MGLN (Magnesium-Doped Lithium Niobate)

MGLN features a high optical damage threshold, low absorption loss, stable refractive index, and broad transparency, making it ideal for room-temperature phase matching. It is well suited for optical modulation, wavelength conversion, high-power lasers, telecommunications, and nonlinear optical devices.

BIBO (Bismuth Borate)

BIBO offers a large effective nonlinear coefficient (3.5–4× LBO, 1.5–2× BBO, ~8× KDP) and high damage threshold, supporting efficient frequency conversion in the visible and blue ranges. It performs well in second-harmonic generation, optical parametric oscillators, and amplifiers.

CaF (Calcium Fluoride)

CaF₂ provides broad transmission from ultraviolet to infrared wavelengths, with low dispersion and high optical clarity. It is commonly used in lenses, windows, prisms, and high-resolution imaging or spectroscopic systems.

PPKTP (Periodically Poled Potassium Titanyl Phosphate)

PPKTP is a nonlinear crystal with a periodically poled structure that provides efficient quasi-phase matching and a nonlinear coefficient three times higher than standard KTP. It is used for SHG, quantum optics experiments, and generating entangled photons across KTP’s transparency range.

With this expansion, SAM reinforces its role as a trusted supplier of advanced crystal materials. The portfolio offers both technical excellence and flexible customization, supporting diverse research and industrial requirements. These crystals provide the foundation for next-generation photonics and laser technologies.

About Stanford Advanced Materials

Founded in 1994, Stanford Advanced Materials (SAM) is a U.S.-based provider of over 7,000 advanced materials to aerospace, technology, medical, and other high-performance markets. Headquartered in Santa Ana, California, SAM utilizes technical proficiency and a worldwide supply chain to deliver reliable, scalable solutions globally.

Betting on Bold: Blue Planet Champions Circular Economy at AVPN Global Conference 2025

HONG KONG, Sept. 17, 2025 /PRNewswire/ — On September 11, Blue Planet Environmental Solutions, a leading force in sustainable waste management, took centre stage at the AVPN Global Conference 2025 in Hong Kong, showcasing how bold bets on circular economy innovation are reshaping Asia’s environmental future.

Bold Ideas. Scalable Impact at AVPN Global Conference 2025
Bold Ideas. Scalable Impact at AVPN Global Conference 2025

Delivering a powerful message under the Social Innovation Track, Prashant Singh, Co-Founder & CEO of Blue Planet, shared the company’s journey from an unconventional idea to a tech-powered platform integrating municipal solid waste, e-waste, plastics, hazardous waste, and biofuels—a first in the industry.

“When we started, no one imagined waste could be reimagined as a single integrated platform. Everyone worked in silos. We bet on circularity, traceability, and zero waste to landfill before it was mainstream. Today, that bet is reality,” Singh said.

He spotlighted Blue Planet’s landfill mining projects, at scale in India, once deemed impossible, now reclaiming hundreds of acres of toxic dumps through technology and public-private partnerships.

“Leadership is not about avoiding risk—it’s about making risk investible, bankable, and scalable,” Singh noted.

Singh also underlined the need for patient, risk-aligned capital and progressive policies to scale circular models, while reaffirming Blue Planet’s commitment to radical transparency, last-mile traceability, and on-ground empowerment as the company’s cultural backbone.

“We don’t sell disruption. We build trust with data, transparency, and impact. Every ton processed, every acre reclaimed, is tracked and verified,” he added.

The AVPN Global Conference 2025, hosted with The Hong Kong Jockey Club Charities Trust, convened over 250 speakers and 100 sessions on climate action, sustainable finance, and inclusive development.

Blue Planet’s participation reinforced its mission: transforming waste into value and pioneering scalable circular economy solutions across Asia.

About Blue Planet

Founded in 2017, Blue Planet is a Singapore headquartered company pioneering regional sustainability through technology-driven and IP-based end-to-end solutions for waste management and upcycling. The company has successfully created an innovative technology driven end-to-end waste management platform. The mission is to apply these technologies across various stages of the waste life cycle. Blue Planet is committed to provide circular economy solutions and achieve its vision of zero waste to landfill.

To learn more about Blue Planet, visit: www.blueplanet.asia

About AVPN

AVPN is the largest network of social investors in Asia, comprising over 600 funders and resource providers across 33 markets. Our mission is to increase the flow and effectiveness of financial, human, and intellectual capital in Asia by enabling members to channel resources towards impact. As an ecosystem builder, AVPN enables its members to connect, learn, act, and lead social impact efforts across key pillars while improving the effectiveness of deployed capital, bringing local field needs, regional expertise, and policy insights to the forefront.

For more information about AVPN and our work, please visit: avpn.asia/

NYSE Content Advisory: Pre-Market Update + Fed decision & StubHub celebrates IPO

NEW YORK, Sept. 17, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

NYSE Content Advisory: Pre-Market Update + Fed decision & StubHub celebrates IPO

Ashley Mastronardi delivers the pre-market update on September 17th

  • Stocks are mixed this morning ahead of the Federal Reserve’s highly anticipated decision on interest rates this afternoon at 2 PM ET. Shortly thereafter, Chair Jerome Powell will deliver remarks
  • According to the latest data, traders are pricing in a more than 95% chance that the Federal Reserve will cut interest rates by 25-basis points to a range of 4.25%. This would mark the Fed’s first interest rate cut since last December.
  • Global online ticket marketplace StubHub celebrates its IPO today. On Tuesday, StubHub priced its IPO at $23.50 per share, valuing the company at $8.6 billion. It will begin trading under the ticker symbol STUB.

Opening Bell
StubHub (NYSE: STUB) celebrates its initial public offering

Closing Bell
Garmin (NYSE: GRMN) celebrates the 2025 Garmin Health Summit

Click here to download the NYSE TV App

Video – https://mma.prnasia.com/media2/2775400/NYSE_Market_Update_Sept_17.mp4

 

UPI Launches Program to Extend Payment Network for International Students

HONG KONG, Sept. 17, 2025 /PRNewswire/ — UnionPay International (UPI), a global leader in payment solutions, announced the launch of its program for international students, in partnership with multiple universities, tuition payment platforms, student housing operators, and local banks. The program features a comprehensive, one-stop cross-border payment solution to facilitate tuition payments, daily purchases, and local card applications, making payment easier and safer for international students in 183 countries and regions.

With the holiday season coming to an end, international students and their families are preparing for a new school year. As the volume of tuition payments increased by 17% year-on-year in the first half of 2025, UnionPay integrates resources to meet cross-border payment needs and to offer cost-effective and seamless services. Its payment solutions are now more accessible thanks to partnerships with international payment platforms, local acquirers and Chinese issuers, facilitating tuition payments, campus spending, and other everyday purchases. With UnionPay products, international students can enjoy a wide range of discounts on retailers, restaurants, transportation, airlines, hotel reservations, and online food delivery.

UPI‘s partnerships with international payment platforms—including Flywire, EasyTransfer, Convera (formerly Western Union), and PayMyTuition—cover thousands of global educational institutions. Official websites of partner universities can accept UnionPay cards through these platforms, with discounts based on real-time currency exchange rates. Partners such as Canada’s CIBC, Australia’s BPAY and iEduPay, New Zealand’s PayPlus, and South Korea’s PayZoom, have made UnionPay more widely accepted.

UPI has teamed up with local banks to issue UnionPay cards in major destinations for international students, such as Hong Kong SAR, Singapore, Japan, South Korea, Australia, Spain, and Canada, allowing students to efficiently complete local card application and to use their cards upon arrival. UnionPay payments are accepted by UK-based student apartment providers, including Unite Students and Chapter-living. Besides, well-known local student housing brands in Australia, such as Scape, Iglu, and UniLodge have also enabled UnionPay online payment services. Additionally, international apartment operators such as Greystar have been integrated into the UnionPay merchant network.

UnionPay acceptance covers 183 countries and regions. International students can thus enjoy seamless and secure payment options across multiple countries, enabling them to integrate into local life more easily. In Hong Kong and Macau SARs, almost all ATMs and merchants accept UnionPay, including MTR tap-and-go, Octopus top-ups with Apple Pay, and popular dining hotspots such as Lan Kwai Fong. UnionPay cards can be used at cafés, supermarkets, and restaurants surrounding universities such as HKUST and HKU. Singapore’s universities and private schools, such as NUS, JCU, and NAFA, accept UnionPay for online tuition payments, and nearly all ATMs and 80% of merchants in the country support the card for dining, shopping, and travel.

In Europe and the UK, UnionPay is accepted by most ATMs, department stores, cafés, restaurants, and tourist attractions. University of Portsmouth, University of Edinburgh, University of Sussex, and Imperial College London take UnionPay for tuition payments on their own websites and through Flywire and Convera. In Canada, over 500,000 merchants, including T&T Supermarket, IKEA, Dollarama, Tim Hortons, and Starbucks support UnionPay. In  Australia, universities including University of Melbourne, University of Sydney, Monash, and University of Queensland accept UnionPay for both online and POS payments. In New Zealand, institutions such as University of Auckland and Victoria University, as well as private schools and language programs, support UnionPay at shops, libraries, and cafés on campus.

As the number of students studying abroad continues to grow, UnionPay leverages its global payment network to make cross-border payment securer and easier with lower costs. In doing so, it provides a stable source of student customers for international banks and merchants, promoting the growth of local consumer markets. As always, UPI welcomes new partners in creating a safer and more convenient payment ecosystem for international students.

Bullish secures New York BitLicense from the NYDFS, paving way for U.S. launch

NEW YORK, Sept. 17, 2025 /PRNewswire/ — Bullish (NYSE: BLSH), an institutionally focused global digital asset platform that provides market infrastructure and information services, today announced that its U.S. digital asset trading and custody business, Bullish US Operations LLC, has been granted a BitLicense and Money Transmission License by the New York State Department of Financial Services (NYDFS). The license, officially defined as a ‘Virtual Currency Business Activity License’ by the NYDFS, allows Bullish to provide institutions and advanced traders in New York State digital asset spot trading and custody services. This is another key step in the expansion of Bullish’s global regulatory footprint.

New York is widely recognized as being at the forefront of virtual currency regulation. Receiving our BitLicense and Money Transmission License from the New York Department of Financial Services is a testament to Bullish’s commitment to regulatory compliance and our dedication to building trusted, institutional-grade digital asset infrastructure in key global markets,” said Tom Farley, CEO of Bullish. “As a former President of the New York Stock Exchange and a proud New Yorker, I look forward to Bullish’s contribution to the city’s thriving financial ecosystem.”

“Securing the New York BitLicense is a significant regulatory milestone for our growth in the U.S. and also signals our credibility to operate within the financial capital of the world,” said Chris Tyrer, President of Bullish Exchange. “We believe that clear regulation drives responsible market evolution and institutional engagement. We look forward to offering New York’s institutions and advanced traders Bullish’s regulated, high-performance digital asset services.”

Prospective institutional customers and advanced traders in New York State and elsewhere in the U.S. who are eager to onboard are encouraged to get in touch with a Bullish relationship manager.

Media: media@bullish.com

About Bullish

Bullish is an institutionally focused global digital asset platform that provides market infrastructure and information services. These include: Bullish Exchange – a regulated and institutionally focused digital assets spot and derivatives exchange, integrating a high-performance central limit order book matching engine with automated market making to provide deep and predictable liquidity. Bullish Exchange is regulated in the United States, European Union, Hong Kong, and Gibraltar. CoinDesk Indices – a collection of tradable proprietary and single-asset benchmarks and indices that track the performance of digital assets for global institutions in the digital assets and traditional finance industries. CoinDesk Data – a broad suite of digital assets market data and analytics, providing real-time insights into prices, trends, and market dynamics. CoinDesk Insights – a digital asset media and events provider and operator of Coindesk.com, a digital media platform that covers news and insights about digital assets, the underlying markets, policy, and blockchain technology. For more information, please visit bullish.com and follow LinkedIn and X.

Use of Websites to Distribute Material Company Information

We use the Bullish Investor Relations website (investors.bullish.com) and our X account (x.com/bullish) to publicize information relevant to investors, including information that may be deemed material, in addition to filings we make with the U.S. Securities and Exchange Commission (SEC) and press releases. We encourage investors to regularly review the information posted on our website and X account in addition to our SEC filings and press releases to be informed of the latest developments.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Sentences containing words such as “believe,” “intend,” “plan,” “may,” “expect,” “should,” “could,” “anticipate,” “estimate,” “predict,” “project,” or their negatives, or other similar expressions of a future or forward-looking nature generally should be considered forward-looking statements and include, without limitation, statements relating to future events or Bullish’s future financial or operating performance, business strategy, and potential market opportunity, including in the United States. Such forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Bullish, are inherently uncertain and are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Factors that may cause results to differ from those expressed in our forward-looking statements include, but are not limited, to our ability to grow our business and operations, including in new geographic locations, the costs or expenditures associated therewith, competition in our industry, and the evolving rules and regulations applicable to digital assets and our industry. You should not place undue reliance on any such forward-looking statements, which speak only as of the date they are made, and Bullish undertakes no duty to update these forward-looking statements.

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease

SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral dose

Additional findings include dose-dependent reductions in PMS1 mRNA, excellent brain penetration, and a favorable safety profile

SKY-0515’s Phase 2/3 FALCON-HD trial in patients in Australia and New Zealand is ongoing 

BOSTON, Sept. 17, 2025 /PRNewswire/ — Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today announced positive results from the first interim analysis of the Part C patient cohort in its Phase 1 clinical trial of SKY-0515, an investigational treatment for Huntington’s disease (HD). At Day 84, patients receiving SKY-0515 demonstrate dose-dependent reductions of mHTT protein in blood including 62% at the 9mg dose. SKY-0515 has been generally well tolerated at both dose levels tested. 

Reduction in mHTT protein level in blood from pre-dose through 84 days of treatment. -- Skyhawk Therapeutics, Inc. ‘Phase 1 Part C patient cohort reduction in mHTT protein level in blood at Day 84,’ 2025; Note: Error bars represent standard error of the mean. Placebo (N=6), 3mg (N=10), and 9mg (N=10) patient treatment is ongoing. (PRNewsFoto/Skyhawk Therapeutics)
Reduction in mHTT protein level in blood from pre-dose through 84 days of treatment. — Skyhawk Therapeutics, Inc. ‘Phase 1 Part C patient cohort reduction in mHTT protein level in blood at Day 84,’ 2025; Note: Error bars represent standard error of the mean. Placebo (N=6), 3mg (N=10), and 9mg (N=10) patient treatment is ongoing. (PRNewsFoto/Skyhawk Therapeutics)

Treatment with SKY-0515 also results in important dose-dependent PMS1 mRNA reduction and demonstrates excellent central nervous system penetration. The overall safety profile has been favorable, supporting the continued clinical development of the program.

“SKY-0515 is reducing mHTT protein to the most impressive extent we’ve seen so far in patients, and crucially the clinical and biomarker data show no safety concerns so far at any dose tested,” said Ed Wild, Professor of Neurology at University College London. “It is great that we are seeing substantial PMS1 reduction as well, which should be a potent combination for treating Huntington’s disease via two of its core pathogenic mechanisms. This is what success looks like at the 3-month timepoint, setting the stage for meaningful impact for people living with HD across the world – for whom an orally administered huntingtin-lowering treatment such as SKY-0515 would be truly transformative.”

“The strength of SKY-0515’s biomarker response after just 84 days of treatment underscores its potential as a transformative therapy for HD,” said Sergey Paushkin, Head of R&D at Skyhawk Therapeutics. “These interim data represent an important milestone for SKY-0515 and highlight the power of Skyhawk’s platform to deliver first-in-class small molecules for devastating diseases with no approved disease-modifying therapies.”

Huntington’s disease is a rare, hereditary, and ultimately fatal neurodegenerative disorder that affects over 40,000 symptomatic patients in the United States, with hundreds of thousands estimated to be affected worldwide. There are currently no approved treatments which slow or halt disease progression. SKY-0515 is Skyhawk’s orally-administered, investigational small molecule RNA splicing modifier developed through the company’s novel RNA-splicing platform, SKYSTAR®.  SKY-0515 is designed to reduce both HTT protein and PMS1 protein, an additional key driver of somatic CAG repeat expansion and HD pathology.

SKY-0515 was developed through Skyhawk’s proprietary integrated platform, SKYSTAR®, and is the first Skyhawk drug in clinical trials. 

Skyhawk expects to put a series of additional novel drugs to treat rare neurological diseases with no presently approved disease modifying therapies in the clinic by the end of 2027. The first is on track to initiate trials in mid-2026.

About SKY-0515’s Phase 1 Clinical Study
SKY-0515’s Phase 1 clinical trial is a first-in-human trial designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics, specifically blood biomarker modulation activity, of SKY-0515 in healthy volunteers and individuals with early-stage Huntington’s disease (HD). The trial is separated into three parts. Parts A and B evaluated SKY-0515 in Healthy Volunteers. Part C is a double-blind placebo-controlled parallel design study of two dose levels of SKY-0515 and placebo of individuals with early-stage HD (HD-ISS Stage 1, 2, or mild Stage 3) for 84 days followed by a 12 month extension of active treatment where all participants will receive either a low or high dose of SKY-0515 in a blinded fashion. The objectives of the study are to evaluate safety, pharmacokinetic, and pharmacodynamic parameters including mutant HTT protein and PMS1 mRNA. Part C enrollment is complete, and topline data from the blinded active treatment extension are expected in mid-2026.

About SKY-0515’s Phase 2/3 FALCON-HD Clinical Study
FALCON-HD (NCT06873334) is a Phase 2/3 randomized, double-blind, placebo-controlled, dose ranging study to evaluate the pharmacodynamics, safety, and efficacy of SKY-0515 in 120 participants with Stage 2 and early Stage 3 HD across 10 sites in Australia and New Zealand. Eligible patients will receive a once-daily oral dose of SKY-0515 at one of three dose levels, or placebo, for a treatment period of at least 12 months. The trial aims to assess the potential of SKY-0515 to modulate RNA splicing and reduce mHTT and PMS1 proteins, which are implicated in the pathology of Huntington’s disease. Additional information about FALCON-HD, including participating sites and eligibility criteria, can be found at ClinicalTrials.gov and www.FALCON-HD.com.

About Skyhawk Therapeutics
Skyhawk Therapeutics is a clinical-stage biotechnology company which uses its proprietary platform, SKYSTAR®, to discover and develop small molecule RNA modulating therapies for the world’s most intractable diseases. For more information visit www.skyhawktx.com.  

Skyhawk Contact
Maura McCarthy
maura@skyhawktx.com

 

 

Cheche Group Expands Partnership with Volkswagen Anhui, Delivering End-to-End Risk Management for New Energy Vehicles

BEIJING, Sept. 17, 2025 /PRNewswire/ — Cheche Group Inc. (NASDAQ: CCG) (“Cheche” or the “Company”), China’s leading auto insurance technology platform, today announced the expansion of its strategic partnership with Volkswagen (Anhui) Automotive Company Limited (“Volkswagen Anhui”), through the agreement with Volkswagen (Anhui)  Digital Sales and Services Co., Ltd. (“DSSO”), as the automaker continues to roll out new models.

Cheche will provide comprehensive risk management services for Volkswagen Anhui’s upcoming ID.EVO model, covering the full spectrum ranging from underwriting to digital claims management. This marks a significant step forward in delivering integrated, tech-enabled insurance solutions tailored to the evolving needs of the new energy vehicle (NEV) market.

The ID.EVO is Volkswagen’s first fully connected, full-size pure electric SUV concept, symbolizing the brand’s ongoing evolution in the electric mobility space. As a trusted partner, Cheche will support Volkswagen’s transformation strategy in China and globally by offering scalable, intelligent insurance infrastructure.

“Our collaboration with Volkswagen Anhui reflects our commitment to enabling the NEV ecosystem with smart, end-to-end insurance solutions,” said Lei Zhang, Founder, CEO, and Chairman of Cheche Group.  “We’re proud to help power the next chapter of sustainable mobility.”

This partnership reinforces Cheche’s position as a key enabler of digital insurance innovation in China’s rapidly growing NEV sector.

About Cheche Group Inc.

Established in 2014 and headquartered in Beijing, China, Cheche is a leading auto insurance technology platform with a nationwide network of around 101 branches licensed to distribute insurance policies across 25 provinces, autonomous regions, and municipalities in China. Capitalizing on its leading position in auto insurance transaction services, Cheche has evolved into a comprehensive, data-driven technology platform that offers a full suite of services and products for digital insurance transactions and insurance SaaS solutions in China. Learn more at https://www.chechegroup.com/en

Safe Harbor Statements

This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements also include, but are not limited to, statements regarding existing and new partnerships and customer relationships, projections, estimation, and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the Company’s ability to scale and grow its business, the Company’s advantages and expected growth, and its ability to source and retain talent, as applicable. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of the Company’s management and are not predictions of actual performance. These statements involve risks, uncertainties, and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to materially differ from those expressed or implied by these forward-looking statements. Further information regarding these and other risks, uncertainties, or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. Although the Company believes that it has a reasonable basis for each forward-looking statement contained in this press release, the Company cautions you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. The forward-looking statements in this press release represent the views of the Company as of the date of this press release. Subsequent events and developments may cause those views to change. Except as may be required by law, the Company does not undertake any duty to update these forward-looking statements.

Cheche Group Inc.:
IR@chechegroup.com

Crocker Coulson
crocker.coulson@aummedia.org
(646) 652-7185

Anker Innovation unveils next-generation products powered by advanced AI, robotics and ultimate innovation

BERLIN, Sept. 17, 2025 /PRNewswire/ — Anker Innovations, a global leader in consumer technology, unveiled its refreshed brand direction and a portfolio of next-generation products at IFA 2025. Taking the stage in Berlin, CEO Steven Yang shared his vision for how Anker will continue solving real consumer challenges and set a new course for the future of smart hardware. At the same time, Anker, Eufy, and soundcore announced product innovations powered by advanced AI and robotics.

Brand and Vision

Unified under its three brands — Anker, Eufy, and soundcore — the company is setting a new course as a global smart-hardware leader. As Steven Yang described on stage, these brands will focus on “igniting new possibilities through ultimate innovation,” creating category-defining products across charging, home energy, smart appliances, home security, creative tools, and audio-video.

Values in Action

This transformation is driven not only by products, but also by Anker Innovations’ value framework — three principles that turn vision into action:

  • First Principle — Break problems down to fundamentals to uncover new paths others overlook.
  • Seek Ultimate — Push beyond easy wins to deliver durable, higher standards.
  • Grow Together — Share success with people, partners, and users; create value fairly and sustainably.

With our value framework and focused brand vision, we are championing a Maker spirit at Anker — creating a playground where our teams can push boundaries and define the next generation of intelligent consumer technology,” said Steven Yang, CEO of Anker Innovations. “This is not about technology for its own sake — it’s about solving real challenges for consumers and igniting possibilities that make life simpler.”

Anker Innovations Product Highlights from IFA 2025

From the IFA stage in Berlin, Anker Innovations unveiled a lineup of innovations that put its refreshed brand vision into practice — showing how AI and robotics are reshaping consumer experiences across its portfolio.

eufyMake unveils AI-powered design tools to inspire creativity in everyday makers.

The UV Printer E1 was celebrated as the world’s first personal 3D-texture UV printer and the most-funded Kickstarter campaign in history, raising $46 million from 17,000 backers. Paired with upgraded Make It Real AI design tools — including multi-modal input, one-click 2D-to-3D texture conversion, and smart object recognition — the E1 lets anyone turn sketches, photos, or text into textured designs on wood, leather, and metal. Backer shipments are already underway, with full retail availability in December 2025.

Eufy leverages AI and advanced stair-climbing robotics to revolutionize floor care — with no floor left behind.

The Robot Vacuum Omni S2 was unveiled as the world’s first robot vacuum with HydroJet™ and long-lasting 30kPa AeroTurbo™ Deep Cleaning system. On carpets, AeroTurbo™ 2.0 delivers powerful, clog-free suction that removes dirt and pet hair from deep in the fibers. Its adaptive chassis lifts up to 5 cm, allowing the S2 to cross thick rugs, layered mats, and even shag carpets that stop other robots cold — and clean them effectively. On hard floors, HydroJet™ 2.0 scrubs with constant downward pressure and real-time pad self-cleaning, eliminating stains instead of spreading them. It will be available later this year in Europe and will launch worldwide in January.

Eufy also unveiled Marswalker, the world’s first stair-climbing carrier for robot vacuums, which automatically carries the S2 between floors. Together, they make whole-home cleaning truly automatic for the first time. Marswalker is slated for the first half of 2026.

Eufy Security brings large-model AI into the home to remove blind spots, end false alerts, and make protection proactive.

Eufy Security unveiled AI Core, the world’s first large-model AI agent for the home. Trained to detect and anticipate more than 100 different scenarios — from a package delivery to a stranger approaching your door — AI Core delivers on-device responses in under three seconds while keeping all data local for complete privacy. Notifications are short, precise, and actionable — so instead of endless alerts, you get clear instructions you can trust.

Eufy Security also launched the eufyCam S4, the first DIY hybrid camera that combines a 4K fixed lens with dual 2K pan-tilt-zoom lenses, providing panoramic coverage and facial detail from up to 15 meters away.

Soundcore is using AI to improve sleep, capture ideas, and reinvent home theater.

The Sleep A30 — the world’s first smart ANC sleep earbuds — launched earlier this year in the U.S. and today in Europe and the UK. They tackle snoring and other disruptions with adaptive ANC and AI-generated brainwave audio. The Sleep A30 are currently available in the US and will become available globally in October.

The AI Voice Recorder, a coin-sized wearable unveiled at IFA, clips to clothing and easily turns conversations into transcripts with summaries, providing 97% accuracy across 100+ languages. It will become available later this year.

Soundcore announced that its Nebula projector line is joining the Soundcore family and unveiled the new Soundcore Nebula X1 Pro — the world’s first mobile theater station. Featuring a 4K triple-laser optical engine for Dolby Vision® and Dolby Atmos® multi-channel spatial sound, the X1 Pro combines theater-grade video with detachable wireless speakers and powered subwoofers, the X1 Pro delivers stunning visuals of Dolby Vision(®) and multidimensional sound of Dolby Atmos(®)for a truely immersive entertainment experience. The X1 Pro launches on Kickstarter on September 23.

Anker Prime brings smart displays to multi-device charging

Anker unveiled its next-generation Prime Series — the most advanced multi-device charging family yet. Each Prime device now includes AnkerSense View — a smart display that shows real-time charging speed and temperature at a glance.

The Prime 160W is the world’s most compact 160W multi-port charger. The Prime 300W Power Bank delivers enough power for two laptops and a phone at once and recharges to 50% in just 15 minutes. The Prime Wireless Charging Station is the world’s first Qi2 25W wireless charger with active cooling and a built-in display. And the Prime Docking Station is the world’s first triple-display charging dock with stable 8K output.

Anker SOLIX Solarbank Multisystem to redefine home energy. 

Already the world’s #1 solar balcony solution, Anker SOLIX announced the all-new Solarbank Multisystem. The modular system connects up to four Solarbank units with the Power Dock, scaling up to 14 kW solar input and 4,8 kW power output. It allows up to 80% bill savings and a four-year payback. The Multisystem’s semi-DIY installation approach cuts installation costs by 85% and future-proofs homes with dual EV charging ports. Complementing it, the slim V1 Smart EV Charger — the world’s first IntelliGesture™ charger — blends solar surplus with real-time tariffs for maximum savings.

About Anker Innovations

Anker Innovations is a global smart hardware technology company dedicated to igniting possibilities through ultimate innovation. Today, the company is harnessing AI and robotics to deliver category-defining products in charging, energy storage, smart appliances, home security, creative tools and audio-video. For more information, visit anker-in.com.